RANDHAWA SIMRAT (EVP, Head of R&D) sold 85.3% of their position (23.12K shares) of DIANTHUS THERAPEUTICS, INC. /DE/ on the open market
Open‑market sale worth $2.46M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+7.50K
Price / share
$17.88
Trade value
$134.10K
% of position
Common Stock
Shares
+6.25K
Price / share
$21.77
Trade value
$136.04K
% of position
Common Stock
Shares
+9.38K
Price / share
$22.07
Trade value
$206.91K
% of position
Common Stock
Shares
−2.60K
Price / share
$105.19
Trade value
$273.49K
% of position
Common Stock
Shares
−7.21K
Price / share
$106.25
Trade value
$766.59K
% of position
Common Stock
Shares
−13.31K
Price / share
$106.74
Trade value
$1.42M
% of position
Net shares
+0.00
Net value
-$1.98M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | M · Option Exercise | +7.50K | $17.88 | $134.10K | 187.5% | 4K | 11.50K |
| Common Stock Direct | 9/1/2026 | M · Option Exercise | +6.25K | $21.77 | $136.04K | 54.3% | 11.50K | 17.75K |
| Common Stock Direct | 9/1/2026 | M · Option Exercise | +9.38K | $22.07 | $206.91K | 52.8% | 17.75K | 27.12K |
| Common Stock Direct | 9/1/2026 | S · Sale | −2.60K | $105.19 | $273.49K | 9.6% | 27.12K | 24.52K |
| Common Stock Direct | 9/1/2026 | S · Sale | −7.21K | $106.25 | $766.59K | 29.4% | 24.52K | 17.31K |
| Common Stock Direct | 9/1/2026 | S · Sale | −13.31K | $106.74 | $1.42M | 76.9% | 17.31K | 4K |
| Total | +0.00 | -$1.98M | ||||||
Stock Option (Right to Buy)
Common Stock
7.50K shares
Shares
−7.50K
Strike price
17.88
Held after
56.78K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
6.25K shares
Shares
−6.25K
Strike price
21.77
Held after
41.68K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
9.38K shares
Shares
−9.38K
Strike price
22.07
Held after
87.50K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock7.50K shares | 9/1/2026 | M · Option Exercise | −7.50K | 17.88 | — | 56.78K |
| Stock Option (Right to Buy) Direct | Common Stock6.25K shares | 9/1/2026 | M · Option Exercise | −6.25K | 21.77 | — | 41.68K |
| Stock Option (Right to Buy) Direct | Common Stock9.38K shares | 9/1/2026 | M · Option Exercise | −9.38K | 22.07 | — | 87.50K |